BackgroundThe Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) published their first European-specific guidelines in 2003. The decision to publish their own recommendations recognized that their historical endorsement of the World Health Organization (WHO) and International Society of Hypertension (ISH) guidelines, with some adaptation to the European situation, fell short of addressing the significant differences in economic resources available, and diagnostic and therapeutic recommendations between Europe and the rest of the world. The 2003 ESH/ESC Guidelines have since been revised and updated in light of changes in the field and in the pu...
This is a review article aiming to make focus on the changes made in the most recent sets of clinica...
At the Congress of the European Society on Arterial Hypertension (AH) in June 2007 in Milan were pre...
AbstractThis article aims to discuss differences in pharmacological treatment through a period of 10...
For several years the European Society of Hypertension (ESH) and the European Society of Cardiology ...
The European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) jointly deve...
During the first half of the past year, guidelines for hypertension management issued by the Joint N...
About a decade ago the Belgian Hypertension Committee endorsed the guidelines for the management of ...
Document reviewers: Guy De Backer (ESC Review Coordinator) (Belgium), Anthony M. Heagerty (ESH Revie...
www.medscape. com To Print: Click your browser's PRINT button. NOTE: To view the article with W...
The 2007 guidelines on hypertension of the European Society of Hypertension (ESH) and the European S...
Hypertension continues to be the most common preventable cardiovascular risk factor in Europe. Blood...
Guidelines for the management of arterial hypertension are regularly updated. This article summarize...
This article aims to discuss differences in pharmacological treatment through a period of 10 years f...
Hypertension is now recognised as a very major contributor to disease burden globally. The close wor...
The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (...
This is a review article aiming to make focus on the changes made in the most recent sets of clinica...
At the Congress of the European Society on Arterial Hypertension (AH) in June 2007 in Milan were pre...
AbstractThis article aims to discuss differences in pharmacological treatment through a period of 10...
For several years the European Society of Hypertension (ESH) and the European Society of Cardiology ...
The European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) jointly deve...
During the first half of the past year, guidelines for hypertension management issued by the Joint N...
About a decade ago the Belgian Hypertension Committee endorsed the guidelines for the management of ...
Document reviewers: Guy De Backer (ESC Review Coordinator) (Belgium), Anthony M. Heagerty (ESH Revie...
www.medscape. com To Print: Click your browser's PRINT button. NOTE: To view the article with W...
The 2007 guidelines on hypertension of the European Society of Hypertension (ESH) and the European S...
Hypertension continues to be the most common preventable cardiovascular risk factor in Europe. Blood...
Guidelines for the management of arterial hypertension are regularly updated. This article summarize...
This article aims to discuss differences in pharmacological treatment through a period of 10 years f...
Hypertension is now recognised as a very major contributor to disease burden globally. The close wor...
The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (...
This is a review article aiming to make focus on the changes made in the most recent sets of clinica...
At the Congress of the European Society on Arterial Hypertension (AH) in June 2007 in Milan were pre...
AbstractThis article aims to discuss differences in pharmacological treatment through a period of 10...